Retatrutide Once Weekly for Pain Management and Weight Loss in Adults with Knee Osteoarthritis and Obesity: A Clinical Review
Retatrutide, a novel triple agonist targeting GIP, GLP-1, and glucagon receptors, significantly reduces knee osteoarthritis pain and body weight in obese adults, according to phase 3 trial data from TRIUMPH-4 and TRIUMPH-1-OA.
